CINECA IRIS Institutional Research Information System

PRETE, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.676
AS - Asia 1.608
EU - Europa 928
SA - Sud America 296
AF - Africa 96
OC - Oceania 1
Totale 5.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.612
SG - Singapore 602
CN - Cina 427
IT - Italia 310
BR - Brasile 248
HK - Hong Kong 225
DE - Germania 148
VN - Vietnam 145
SE - Svezia 77
FR - Francia 75
AT - Austria 65
GB - Regno Unito 49
FI - Finlandia 46
JP - Giappone 35
BG - Bulgaria 32
CA - Canada 31
CI - Costa d'Avorio 30
IN - India 28
BD - Bangladesh 22
KR - Corea 22
SN - Senegal 21
AR - Argentina 20
RU - Federazione Russa 20
PL - Polonia 19
TR - Turchia 19
MA - Marocco 18
MX - Messico 18
EE - Estonia 15
NL - Olanda 15
ZA - Sudafrica 13
ES - Italia 11
IQ - Iraq 10
UZ - Uzbekistan 10
ID - Indonesia 9
PK - Pakistan 9
UA - Ucraina 9
EC - Ecuador 7
CL - Cile 6
CZ - Repubblica Ceca 6
IE - Irlanda 5
JO - Giordania 5
MG - Madagascar 5
PH - Filippine 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
GR - Grecia 4
KE - Kenya 4
LT - Lituania 4
BE - Belgio 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
HN - Honduras 2
JM - Giamaica 2
MC - Monaco 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 5.605
Salva come PNG Salva come JPEG
Città #
Dallas 562
Singapore 359
Ashburn 349
San Jose 330
Hong Kong 220
Santa Clara 160
Chandler 131
Shanghai 92
Munich 88
New York 85
Los Angeles 81
Beijing 65
Vienna 61
Pisa 57
Milan 51
Fairfield 49
Boardman 46
Ho Chi Minh City 46
Hefei 34
Sofia 32
Tokyo 32
Abidjan 30
Hanoi 30
Houston 30
Frankfurt am Main 27
Lauterbourg 27
Woodbridge 27
Council Bluffs 26
Helsinki 26
Redondo Beach 26
Florence 25
São Paulo 25
Buffalo 24
Rome 22
Seoul 22
Cambridge 21
Dakar 21
Princeton 21
Lawrence 19
Orem 19
Seattle 19
Wilmington 19
London 17
Turku 17
Medford 15
Warsaw 14
Atlanta 12
Columbus 12
Denver 12
Phoenix 12
Poplar 12
Brooklyn 11
Casablanca 11
Ogden 11
Johannesburg 10
Montreal 10
Cascina 9
Chicago 9
Düsseldorf 9
Lucca 9
Nuremberg 9
San Diego 9
Serra 9
Tashkent 9
Belo Horizonte 8
Fuzhou 8
Istanbul 8
Baltimore 7
Boston 7
Stockholm 7
Washington 7
Amsterdam 6
Bologna 6
Changchun 6
Mexico City 6
Mumbai 6
Paris 6
Quanzhou 6
Toronto 6
Amman 5
Antananarivo 5
Baghdad 5
Bremen 5
Chiesina Uzzanese 5
Da Nang 5
Hải Dương 5
Modena 5
Presidente Prudente 5
Redmond 5
Rio de Janeiro 5
San Francisco 5
Turin 5
Vancouver 5
Wroclaw 5
Ankara 4
Ann Arbor 4
Baku 4
Caracas 4
Chennai 4
Dublin 4
Totale 3.883
Salva come PNG Salva come JPEG
Nome #
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 214
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 189
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 166
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 164
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 162
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 162
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 156
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma 156
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 155
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 151
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 146
Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature 140
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 133
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? 132
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 131
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 129
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 129
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 129
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 128
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 126
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 125
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 119
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer 118
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 116
Firm mass in thyroid of an elderly patient: Not always cancer 114
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 113
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 112
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 110
Use of non-nutritive-sweetened soft drink and risk of gestational diabetes 110
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 109
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 105
Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3) 104
Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report 103
The challenge of the differential diagnosis between brown tumors and metastases in parathyroid carcinoma: a case report 98
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 98
MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY 94
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 91
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 91
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination 90
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 86
Inflammation-based scores in patients with pheochromocytoma 85
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 78
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 76
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 64
State of the Art in 3D Culture Models Applied to Thyroid Cancer 62
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 59
Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease 41
Calcitonin Thresholds for Prediction of Medullary Thyroid Carcinoma and its Clinical Response in MEN2A Gene Carriers 22
Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinoma 20
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment 19
null 19
18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response 19
Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience 18
Prevalence and genetics of "de novo" MEN2 syndromes 18
A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center 7
Totale 5.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022174 7 0 4 0 26 22 13 9 11 12 16 54
2022/2023452 40 49 41 38 51 51 2 41 96 3 32 8
2023/2024343 17 29 54 26 42 66 21 3 5 9 27 44
2024/20251.562 21 58 28 85 160 114 167 86 156 172 199 316
2025/20262.979 202 474 394 305 303 167 374 92 155 245 109 159
2026/202720 20 0 0 0 0 0 0 0 0 0 0 0
Totale 5.711